Navigation Links
Nephros Reports 2009 Third Quarter Financial Results
Date:11/12/2009

17,000 in the corresponding period of 2008. The decrease of approximately $726,000 or 48% is primarily related to: decrease in research and development expenses of approximately $129,000 due to the fact that there was no clinical trial being conducted in the three months ended September 30, 2009 compared to the same period in 2008; decrease in selling, general and administrative expenses of approximately $566,000 resulting from decreased legal, insurance, rent, personnel and other expenses; and a reduction in depreciation expense of approximately $31,000.

The Company's net loss was approximately $395,000 or $0.01 per basic and diluted common share for the third quarter of 2009 compared to a net loss of approximately $1,346,000 or $0.04 per basic and diluted common share in the third quarter of 2008.

As of September 30, 2009, Nephros had cash and cash equivalents in the amount of $1,795,000.

End-Stage Renal Disease (ESRD) Products

Nephros completed the patient treatment phase of the U.S. clinical trial evaluation of the OLpur(TM) H2H(TM) module and OLpur(TM) MD 220 filter during the second quarter of 2008. The Company submitted the clinical data to the U.S. Food and Drug Administration ("FDA") with the 510(k) application for U.S. marketing approval of these products in November 2008. Following its review of the application, the FDA requested additional information from us. Nephros replied to the FDA inquiries on March 13, 2009. We have made inquiries to the FDA about the status of our application and have been informed that our application is still under review. As of September 30, 2009, Nephros has not received a formal decision or a request for additional information from the FDA for this 510(k) application. Nephros believes that, if approved, its technology would be the first FDA-approved on-line HDF therapy available in the U.S.

Water Ultrafiltration Products

On July 1, 2009, Nephr
'/>"/>

SOURCE Nephros, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
2. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
3. Corgenix Reports Financial Results for First Quarter of Fiscal 2010
4. Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
5. Pharmos Corporation Reports 2009 Third Quarter Results
6. MedCath Corporation Reports Fourth Quarter Earnings
7. Cardiogenesis Reports Third Quarter 2009 Results
8. Vion Pharmaceuticals Reports 2009 Third Quarter and Nine-Month Results
9. PLC Systems Reports Third Quarter 2009 Results; Announces Distribution Agreement for RenalGuard(R) in Brazil
10. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
11. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Caradigm ... 4.0, a solution designed to help healthcare ... and data while supporting their compliance with ... Provisioning represents a milestone in the delivery ... analytics capabilities for health systems. ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... has recently added DrugPatentWatch to its ... http://www.bharatbook.com/drugpatentwatch-tour.pdf )      (Logo: ... comprehensive information on pharmaceutical, drug patents ... supports the critical business functions of ...
(Date:6/19/2013)... DST Health Solutions, LLC (DSTHS), a leading ... integrated delivery systems, and health care providers, has announced ... (MDMS) has jumped significantly. A customizable ... of medical prescription drug claims, MDMS allows ... drug claims processes. As specialty drug demand grows due ...
Breaking Medicine Technology:Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3
(Date:6/19/2013)... June 19, 2013 The benefits, ... the sauna but the overall experience for the majority ... positive health-wise. , Mr Mouw, whose Virgina-based company enjoys ... Society’s statement by saying that the type of sauna ... a number of counterfeit imitations which frankly, can be ...
(Date:6/19/2013)... Daily Gossip issued a press release informing people that ... published on their website at the end of June. Reporters ... about the information they will find on the website. , ... Gossip, the article is a review of the newly published ... during the vast research he has performed that it is ...
(Date:6/19/2013)... 2013 Researchers from the Icahn ... new studies at ENDO 2013, The Endocrine Society’s ... in San Francisco.     , Mount Sinai researchers showed new ... of prostastic acid phosphatase (PAP) in Prostate Cancer (PCa) ... thyroid gland; revealed the prevalence of primary aldosteronism (PA) ...
(Date:6/19/2013)... HASCO Medical, Inc. (OTCBB: HASC), ... purchase privately held Auto Mobility Sales, Inc. of ... vehicle sales, service and rentals in southeastern Florida. ... and expands HASCO's strategy of becoming a leading ... The acquisition is subject to customary closing conditions, ...
(Date:6/19/2013)... Nashville, TN (PRWEB) June 19, 2013 ... the appointment of Dr. John Baxter to Vice President, ... currently serves as Director, Mental Health Services for CCA. ... "It is an honor and great privilege to lead ... offers the unique opportunity to serve society and our ...
Breaking Medicine News(10 mins):Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2
... Children with eczema, a chronic skin condition that often begins ... food allergies. The number of children with eczema is ... new study soon to be published in The Journal ... eczema. Researchers found that dog ownership among children with ...
... breast cancer that also have mutations in the BRCA gene ... those with the same disease without the deleterious genetic mutation, ... Cancer Center. The findings may offer a direction for ... negative breast cancer patients, as well as highlight the unique ...
... HealthDay Reporter , WEDNESDAY, Sept. 29 (HealthDay ... effective in relieving knee pain from osteoarthritis, researchers are ... has halted a phase 3 trial of the drug ... replacements. Lead researcher Dr. Nancy E. Lane, director ...
... a three-year, $200,000 grant to Claudio Soto, Ph.D., professor ... Center at Houston (UTHealth), to pursue a procedure that ... of this project is to develop an efficient and ... can tell people they are in the process to ...
... Melvin and Bren Simon Cancer Center have published the ... brain tissue can occur in breast cancer patients undergoing ... to as "chemobrain," have been known for years. ... brain imaging to study women with breast cancer before ...
... September 28, 2010 -- The Accreditation Council for ... approved a set of requirements that are a ... professionalism, transitions in care, and resident well-being. Included ... nation,s 111,000 residents training in ACGME accredited teaching ...
Cached Medicine News:Health News:Dog ownership is associated with reduced eczema in children with dog allergies 2Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 2Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 3Health News:Novel Drug Eases Osteoarthritis Knee Pain 2Health News:IU researchers: Chemotherapy alters brain tissue in breast cancer patients 2Health News:ACGME board approves final duty hour and supervision standards for resident education 2Health News:ACGME board approves final duty hour and supervision standards for resident education 3
Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....
For the quantitative determination of total glucose in serum....
Glucose reagent is used for the quantitative determination of glucose in human serum....
Medicine Products: